COVID-19 Impact on Glycomics/Glycobiology Market By Key Manufacturers, By Type (Enzymes, Instruments, Kits, Carbohydrates, Oligosaccharides, Reagents & Chemicals), By Application (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Outlook to 2026
Report ID: 392062 | May 2020 | No. of Pages: 120 |
Covid-19 Impact Analysis & Forecast
Global Glycomics / Glycobiology Market size is estimated to record USD 2429.85 Million by 2026, at a Compound Annual Growth Rate (CAGR) of 14.5%.

Glycomics / Glycobiology Market report (2019-2026) includes global market size, trends, company overview, competition analysis, and forecast. The global market is projected to record USD 941.76 Million in 2019.

The market report includes Glycomics / Glycobiology market definition, segmentation, executive summary, value chain analysis, porter’s analysis, research methodology and new industry trends which includes drivers, restraints and market opportunities. Other section includes regional analysis which is conducted on various factors such as cost of the product/services, raw material supplies, production capacities, availability and demand analysis. Further section includes analysis and opportunity assessment for key companies. This section includes competition analysis, market share analysis, key developments of the industry, and company profiling. Within company profiling, detailed analysis of key players including company overview, financial information analysis, product offerings, and recent development of company. This also includes SWOT analysis that highlights the current position of company among competitors and in market.
Glycomics / Glycobiology Market Dynamics
The market report comprises of market dynamics/trends section that includes driving factors, restraints, and opportunities faced by the market players and stakeholders. These market trends includes core factors such as driving factor and restraining factor and extrinsic factors such as opportunities. These factors are not only confined with the current market situation as well as with the forecasted period.
Glycomics / Glycobiology Market Competitive Landscape
The key companies in Glycomics / Glycobiology Market are Merck KGaA, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Takara Bio, S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation, Asparia, Glycomics S.L., Bio-Techne, Bruker Corporation, Danaher Corporation.
Focus Areas of Market
• Global Market Analysis (2019-2026)
• Cost Analysis
• Market Growth Factors
• Market Strategies
• Key Companies Analysis
• Industry Growth Analysis
Regional Analysis
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Company Profile Inclusions
• Business Overview
• Financial Information
• Market Share Analysis
• Recent News
• SWOT Analysis
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis

Chapter 5. Glycomics / Glycobiology Industry, By Type
5.1. Glycomics / Glycobiology Market, By Type 2019-2026
5.1. Enzymes
5.2. Instruments
5.3. Kits
5.4. Carbohydrates
5.5. Oligosaccharides
5.6. Reagents & Chemicals

Chapter 6. Glycomics / Glycobiology Industry, By Application
6.1. Glycomics / Glycobiology Market, By Application 2019-2026
6.1. Academic Research Institutes
6.2. Pharmaceutical and Biotechnology Companies
6.3. Clinical Laboratories

Chapter 7. Glycomics / Glycobiology Industry, By Region
7.1. Glycomics / Glycobiology Market, By Region 2019-2026
7.1.1. North America
7.1.1.1. U.S
7.1.1.1. Canada
7.1.1.2. Mexico
7.1.2. Europe
7.1.2.1. U.K.
7.1.2.2. Germany
7.1.2.3. France
7.1.2.4. Rest of the Europe
7.1.3. Middle East & Africa (MEA)
7.1.3.1. GCC
7.1.3.2. North Africa
7.1.3.3. South Africa
7.1.3.4. Rest of MEA
7.1.4. Latin America (LATAM)
7.1.4.1. Brazil
7.1.4.2. Rest of LATAM
7.1.5. Asia Pacific (APAC)
7.1.5.1. India
7.1.5.2. China
7.1.5.3. Japan
7.1.5.4. Rest of the APAC

Chapter 8. Competitive Landscape
8.1.1. Key Strategies Adopted by Players
8.1.2. Market Share/Positioning Analysis

Chapter 9. Company Profiles
9.1. Merck KGaA
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Agilent Technologies
9.3. Thermo Fisher Scientific
9.4. New England Biolabs
9.5. Shimadzu Corporation
9.6. Takara Bio
9.7. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
9.8. Waters Corporation
9.9. Asparia Glycomics S.L.
9.10. Bio-Techne
9.11. Bruker Corporation
9.12. Danaher Corporation

Chapter 10. Appendix
10.1. About Us
10.2. Glossary of Terms
10.3. Disclaimer
1. Merck KGaA
2. Agilent Technologies
3. Thermo Fisher Scientific
4. New England Biolabs
5. Shimadzu Corporation
6. Takara Bio
7. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
8. Waters Corporation
9. Asparia Glycomics S.L.
10. Bio-Techne
11. Bruker Corporation
12. Danaher Corporation

Select License Type
USD $4250
USD $6250
Connect With Us

+1-707-633-0404